Your event should be here ! To publish, manage, promote... To learn or to be formed ... Online registrations

Site language : English - Français
Ref : 33198
Event :Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs)

Dates :Wednesday August 25th, 2021 - Thursday August 26th, 2021

Location :San Jose, United States

Type :Conference & Seminar - International audience

Accreditation :--


 

Further information

Editorial

The globalization of the pharmaceutical supply chain has resulted in the increased use of Contract Manufacturing Organizations (CMOs). The use of CMOs provides many benefits; however, it also presents unique compliance risks, particularly since operations are not under your direct control. Compliance risks are highlighted by FDA Warning Letter trends, the majority of which are related to serious cGMP compliance and data integrity issues at foreign CMO sites.

If you use CMOs, your firm is fully responsible for product quality, safety, efficacy, and cGMP compliance. Furthermore, FDA has clearly stated that firms using CMOs will be held accountable for CMO compliance to cGMPs, as well as for CMO adherence to Sponsor regulatory commitments. Issues identified at your CMO may result in FDA 483s and/or Warning Letters issued to your firm. Therefore, it is imperative that your organization have a robust CMO management system. At the end of the day, your ability to provide proper quality oversight of CMOs is the key to assuring product safety and safeguarding your firm’s compliance profile.

This seminar will help all personnel responsible for CMO oversight understand how to ensure effective quality oversight of CMOs- from start to finish. In-depth focus will be placed on Selection and Qualification, CMO Audits, Quality Agreements, Oversight of CMO Operations, and Review of Key CMO Records. Considerations for different types of manufacturing will be highlighted, and techniques for managing difficult CMO situations will be addressed. Techniques for assuring robust CMO Oversight programs in light of COVID-19 restrictions will also be discussed.

This is a practical how-to course, designed to provide participants with skills they can immediately apply to CMO oversight within their own organizations. Case studies will allow participants to practice skill sets in cooperation with the instructor.


 

Objectives

  • Understand the CMO business model
  • Understand the regulatory requirements for CMO quality oversight
  • Understand how to structure your organization for effective CMO oversight
  • Understand key points for selecting and qualifying CMOs
  • Know how to prepare for and conduct CMO Audits
  • Know how to develop a Quality Agreement and how to execute it
  • Understand key points for reviewing CMO records
  • Know how to resolve issues identified in CMO records
  • Know how to manage CMOs on an ongoing basis

Program

Day 01(7:30 AM to 1:30 PM PDT)
  • The CMO Business Model
  • What is CMO Oversight?
  • CMO Oversight and COVID-19 Restrictions
  • Regulatory Requirements for CMO Oversight
  • FDA Expectations and Warning Letters
  • Structuring Your Organization for CMO Oversight
    • Manufacturing
    • Chemistry / Laboratory
    • Quality Assurance
    • Regulatory Affairs
    • Project Management
    • Group Exercise # 1- Structuring Your Organization
  • CMO Selection and Qualification
    • Overall Considerations
    • Selection Criteria / Process
    • Qualification Criteria / Process
    • Evaluating CMOs vs. Selection / Qualification Criteria
    • Case Study # 2- Example of Selection Scoring Matrix
  • CMO Audits (Remote Auditing Perspective)
    • Overall Considerations
    • Qualification vs. Routine Audits
    • CMO Questionnaires
      • Purpose of Questionnaires
      • Questionnaire Topics / Responses
    • Audit Planning
      • Audit Purpose / Scope
      • Audit Agenda
    • Audit Execution
      • Document Review / Interviews
      • Time Management
      • Audit Findings / CAPAs
    • Group Exercise # 3- Audit Agenda
  • The Quality Agreement
    • Regulatory Requirements
    • General Elements of the Quality Agreement
    • Negotiating the Quality Agreement
    • Executing the Quality Agreement
    • Case Study # 4- Quality Agreement: Key Pitfalls
Day 02(7:30 AM to 1:30 PM PDT)
  • Getting to Know Your CMO
    • Understanding CMO Operations
    • Operational/Communication Style
    • Case Study # 5- CMO Personality Types
  • Review of Key CMO Records
    • Batch Records
    • Change Controls
    • Deviation Investigations / CAPA
    • OOS Investigations
  • Hot Topic- Data Integrity
  • Ongoing CMO Oversight
    • Overall Considerations
    • Elements of Effective Ongoing CMO Oversight


 

Speakers

Andrew Campbell has 25 years of pharmaceutical quality assurance and quality systems experience in both industry and consulting roles. Mr. Campbell has worked in clinical supply and commercial manufacturing environments, and has experience with integrated manufacturing and contract manufacturing business models. He has extensive expertise in the areas of deviation - CAPA, change control, GMP auditing, GMP training, and regulatory inspection preparation and management.

Working with large and small companies, Mr. Campbell has successfully developed, remediated and implemented key quality systems. He is a skilled GMP auditor, and has audited multiple API, drug product, packaging, testing, and distribution facilities. He is an experienced GMP trainer, and has developed customized and interactive training presentations for many companies. He has also provided FDA inspection support for several clients, including readiness training, on-site assistance during inspections, and authoring written responses to inspectional observations. Prior to becoming a consultant in 2007, Mr. Campbell worked for Ligand Pharmaceuticals as director of quality systems.


 

Organizing committee

Complianceonline
 

Location

Map and directions
Conference address :
San Jose
United States
Map and directions

Further information

To access the information you need to be connected. Creating an account is easy and free!

Log to your account
Register on Doctorama

Details

Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs) Pharmacy
pharmaceutical contract laboratories, pharmaceutical contract manufacturers in usa, contract drug manufacturers, pharmaceutical contract companies, contract drug manufacturing companies, pharma contract manufacturers, pharmaceutical contract manufacturing companies, outsourcing in pharmaceutical industry
Professionals
-- -- --
--

Other

For more information on Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs), plsase contactr ComplianceOnline

To display announcer website, obtain a letter of invitation, you must be logged

Log to my account
Register on Doctorama


Recommend this event